CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • E. Van Cutsem - , KU Leuven (Author)
  • G. Bodoky - , University of Nebraska Medical Center (Author)
  • J. Kyung Roh - (Author)
  • G. Folprecht - , Department of Internal Medicine I (Author)
  • Y. S. Park - , Sungkyunkwan University (SKKU) (Author)
  • J. L. Van Laethem - , Université libre de Bruxelles (ULB) (Author)
  • J. L. Raoul - , Unicancer Group (Author)
  • F. Ciardiello - , University of Campania Luigi Vanvitelli (Author)
  • P. Lebrun - , University Hospital Sarajevo (Author)
  • P. Rougier - , INSERM - Institut national de la santé et de la recherche médicale (Author)

Details

Original languageGerman
Pages (from-to)235-235
Number of pages1
JournalEuropean Journal of Cancer : EJC Supplements
Volume5
Issue number4
Publication statusPublished - Sept 2007
Peer-reviewedYes

Conference

Title14th European Cancer Conference (ECCO 14)
Duration23 - 27 September 2007
CityBarcelona
CountrySpain

External IDs

ORCID /0000-0002-9321-9911/work/142252039

Keywords

Sustainable Development Goals